Biocon has reported results for fourth quarter and year ended March 31, 2022.
The company has reported a fall of 43.72% in its net profit at Rs 38.10 crore for the quarter under review as compared to Rs 67.70 crore for the same quarter in the previous year. However, total income of the company increased by 7.83% at Rs 578.50 crore for Q4FY22 as compared Rs 536.50 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 19.40% in its net profit at Rs 238.90 crore for the quarter under review as compared to Rs 296.40 crore for the same quarter in the previous year. However, total income of the company increased by 20.93% at Rs 2,476.10 crore for Q4FY22 as compared Rs 2,047.50 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a fall of 69.30% in its net profit at Rs 86.10 crore as compared to Rs 280.50 crore for the previous year. Total income of the company decreased by 11.62% at Rs 1,925.40 crore for year under review as compared to Rs 2,178.60 crore for year ended March 31, 2021.
For the year ended March 31, 2022, on the consolidated basis, the company has reported a fall of 8.82% in its net profit at Rs 771.60 crore as compared to Rs 846.20 crore for the previous year. Total income of the company increased by 13.51% at Rs 8,396.70 crore for year under review as compared to Rs 7,397.60 crore for year ended March 31, 2021.
